KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Neogenomics (NEO) Long-Term Debt Repayments: 2009-2019

Historic Long-Term Debt Repayments for Neogenomics (NEO) over the last 10 years, with Jun 2019 value amounting to $3.2 million.

  • Neogenomics' Long-Term Debt Repayments rose 97.72% to $3.2 million in Q2 2019 from the same period last year, while for Jun 2019 it was $39.0 million, marking a year-over-year increase of 14902.31%. This contributed to the annual value of $5.0 million for FY2019, which is 85.88% down from last year.
  • As of Q2 2019, Neogenomics' Long-Term Debt Repayments stood at $3.2 million, which was up 78.24% from $1.8 million recorded in Q1 2019.
  • Neogenomics' 5-year Long-Term Debt Repayments high stood at $51.1 million for Q4 2016, and its period low was -$4.1 million during Q4 2017.
  • Over the past 3 years, Neogenomics' median Long-Term Debt Repayments value was $1.5 million (recorded in 2017), while the average stood at $4.5 million.
  • As far as peak fluctuations go, Neogenomics' Long-Term Debt Repayments spiked by 4,149.88% in 2016, and later slumped by 108.07% in 2017.
  • Over the past 5 years, Neogenomics' Long-Term Debt Repayments (Quarterly) stood at $1.2 million in 2015, then skyrocketed by 4,149.88% to $51.1 million in 2016, then tumbled by 108.07% to -$4.1 million in 2017, then surged by 2,260.50% to $32.4 million in 2018, then surged by 97.72% to $3.2 million in 2019.
  • Its Long-Term Debt Repayments stands at $3.2 million for Q2 2019, versus $1.8 million for Q1 2019 and $32.4 million for Q3 2018.